Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery

Status Completed

Clinical Trial Summary

This study will evaluate the efficacy and safety of the use of bevacizumab (Avastin) as an adjunctive medication during pterygium surgery in preventing pterygium recurrence. A pterygium is a white fleshy growth on the surface of the eye, which can be removed surgically. However, after surgical removal, pterygia can recur. One way of minimizing recurrence is by applying a medication called mitomycin C to the surface of the eye during pterygium surgery. However, mitomycin is associated with certain side effects, such as thinning of the eye wall and poor wound healing. Bevacizumab has a different mechanism of action and there is some evidence that it may be useful in preventing pterygium recurrence. In this study, the safety and efficacy of adjunctive intraoperative use of bevacizumab and mitomycin C for preventing pterygium recurrence will be directly compared.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Pterygium

Clinical Trial Details

NCT number	NCT01115517
Study type	Interventional
Source	The University of Texas Health Science Center, Houston
Contact
Status	Completed
Phase	Phase 2
Start date	October 2010
Completion date	July 2015

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02641132` - Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count.	Phase 4
Completed	`NCT02342392` - Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study	Phase 2/Phase 3
Recruiting	`NCT01387971` - Using Impression Cytology to Observe the Cytological Changes of Ocular Surface Cells in Various Ocular Surface Disorders	N/A
Recruiting	`NCT05978687` - The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision	Phase 4
Not yet recruiting	`NCT06042296` - Expression of CD44, PCNA and E-cadherin in Pterygium Tissue
Completed	`NCT04022811` - Effect of Bromfenac on Pain Related to Pterygium Surgery	Phase 4
Recruiting	`NCT01261455` - Prospective Randomized Pilot Study Comparing Inferior Versus Superior Conjunctival Autografts for Primary Pterygia	N/A
Recruiting	`NCT01249235` - Bandage Contact Lens and Oral Analgesics Versus Patching and Oral Analgesics for Pain Following Pterygium Surgery	N/A
Completed	`NCT00768963` - Ranibizumab for the Inhibition of Neovascularization in Pterygia	Phase 1
Completed	`NCT00949728` - Conjunctival Autologous Transplantation Using Fibrin Glue in Primary Pterygia	N/A
Recruiting	`NCT00563277` - Surgical Treatment of Concurrent Cataract and Primary Pterygium	N/A
Completed	`NCT00346450` - Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation	Phase 3
Completed	`NCT03533244` - A Study of the Response to AG-86893 in Patients With Pterygium Hyperemia	Phase 2
Completed	`NCT04403516` - Dextenza in Pterygium Surgery	Phase 4
Recruiting	`NCT02911532` - Tissue Engineering Conjunctiva for the Treatment of Pterygium and Atretoblepharia	N/A
Not yet recruiting	`NCT03304366` - Corneal Changes With Pentacam Before and After Pterygium	N/A
Unknown status	`NCT02015000` - Surgical Result of Pterygium Extended Removal Followed by Fibrin Glue Assisted Amniotic Membrane Transplantation	N/A
Completed	`NCT00344201` - Assessment of Fibrin Glue in Pterygium Surgery and Other Forms of External Eye Surgery	Phase 1
Recruiting	`NCT00326560` - Comparison of Glue With Sutures for Pterygium Surgery	Phase 3
Not yet recruiting	`NCT03314389` - The Corneal and Conjunctiva Sensation Before and After Pterygium Surgeries	N/A